Galderma Research & Development

Itaru Suzuki

Claire Bouix-Peter

Jean-Claude Pascal

Pascale Mauvais

Nicolas Rodeville

Pascal Collette

Philippe Andres

Johannes Voegel

Sandrine Rethore

Philippe Martel

Isabelle Pelisson

Samuel Tabet

Guillaume Lafitte

The present invention relates to novel compounds derived from oxoazetidine corresponding to general formula (I) to the compositions containing same, to the process for preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions. 

Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics

A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.

Combination of a prostaglandin receptor agonist and an MC1R receptor agonist for the treatment and/or prevention of pigmentation disorders

Melanocortin receptor modulators, processes for preparing them and use thereof in human medicine and cosmetics are described. Melanocortin receptor modulators corresponding to formula (I): compositions containing them, processes for their preparation and their use in pharmaceutical or cosmetic compositions are also described.

Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics

Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.

Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics

Growing community of inventors

Fayence, France

Itaru Suzuki